**Question:** Alpha fetoprotein is raised in all except: September2011

**Core Concept:** Alpha fetoprotein (AFP) is a glycoprotein produced primarily by the yolk sac, fetal liver, and fetal gastrointestinal tract during pregnancy. It is used as a marker for fetal hepatoblastoma, neuroblastoma, and other malignancies.

**Why the Correct Answer is Right:** AFP levels are typically elevated in conditions like fetal hepatoblastoma, neuroblastoma, and other malignancies due to increased production in fetal liver and gastrointestinal tract. However, AFP levels are not typically elevated in September2011, as it is a term for the ninth month of pregnancy, and AFP levels should have decreased due to fetal maturity.

**Why Each Wrong Option is Incorrect:**

A. AFP levels are elevated in fetal hepatoblastoma, which is a type of malignancy that occurs in the liver during fetal development. AFP is produced by the tumor cells, leading to elevated levels. This option is incorrect because AFP levels should be elevated in the presence of hepatoblastoma.

B. AFP levels are elevated in neuroblastoma, another type of fetal malignancy that arises from the neural crest cells. AFP is produced by the tumor cells, increasing AFP levels. This option is incorrect because AFP levels should be elevated in neuroblastoma cases.

C. AFP levels are elevated in Down syndrome, a genetic disorder characterized by trisomy 21. This option is incorrect because AFP levels are not typically associated with Down syndrome.

D. AFP levels are elevated in cases of a ruptured ectopic pregnancy, where the fertilized egg implants in a location other than the uterus. This option is incorrect because AFP levels are not typically associated with ectopic pregnancy.

**Clinical Pearl:**

Understanding the normal physiological changes during pregnancy, as well as the clinical scenarios where AFP levels may be elevated, is crucial for accurate diagnosis in clinical practice. In general, AFP levels should be elevated in fetal hepatoblastoma, neuroblastoma, and other malignancies, while remaining normal in Down syndrome and ectopic pregnancy. Monitoring AFP levels can be useful in detecting early signs of fetal abnormalities and guiding clinical decision-making.